← Human Trials & Peer-Reviewed Studies
The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial
Plain-language guide to PMID 34727201 (2022): double-blind randomized controlled trial study of L-Carnitine, insulin resistance, prediabetes & type 2 diabetes.
Key Facts
- PMID
- 34727201
- Journal
- European journal of nutrition
- Year
- 2022
- Study type
- Randomized Controlled Trial
- Authors
- Sangouni AA et al. (6 authors)
- DOI
- 10.1007/s00394-021-02659-0
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial paper looks at L-Carnitine in the context of insulin resistance, prediabetes & type 2 diabetes.
Polycystic ovary syndrome (PCOS) is a common endocrine disorder among reproductive-age women.
Insulin resistance and dyslipidemia are linked to PCOS.
L-Carnitine supplementation as a management strategy for women with PCOS has been proposed.
Why It Was Studied
Registered on 30th December 2019 at Iranian Registry of Clinical Trials (IRCT20191016045131N1).
Who Took Part
PubMed tags the participants as women only.
This randomized, double-blind, controlled clinical trial, was conducted on 62overweight/obese women with PCOS.
How the Study Was Run
In design terms this was a randomized, double-blind and placebo-controlled study.
The participants were allocated by chance, so the L-Carnitine group and the comparison group should start out alike.
Neither the participants nor the staff measuring them knew who was on L-Carnitine, so expectations could not easily colour the readings.
Some participants received a placebo instead of L-Carnitine, giving a reference point.
What Was Measured
The subject headings attached to it are Carnitine, Cholesterol, HDL, Dietary Supplements, Insulin, Insulin Resistance, Iran and Lipids.
The authors tagged it with the keywords L-Carnitine, Lipid profile, Polycystic ovary syndrome and Sex hormone-binding globulin.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of L-Carnitine in people with insulin resistance, prediabetes & type 2 diabetes.
Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2022 (European journal of nutrition), a journal based in Germany.
More context: the L-Carnitine compound page, Insulin resistance, prediabetes & type 2 diabetes research.
Our Notes on the Compound
L-Carnitine: An amino acid derivative that carries fatty acids into mitochondria for energy production.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.